scispace - formally typeset
M

Marco Andolfi

Researcher at University of Perugia

Publications -  25
Citations -  286

Marco Andolfi is an academic researcher from University of Perugia. The author has contributed to research in topics: Cardiothoracic surgery & Lung cancer. The author has an hindex of 8, co-authored 23 publications receiving 185 citations.

Papers
More filters
Journal ArticleDOI

The role of bronchoscopy in the diagnosis of early lung cancer: a review.

TL;DR: Although tissue biopsy remains the gold standard for diagnosing malignant/premalignant airway disease and some techniques are still investigational, bronchoscopic technologies can be considered the safest and most accurate tools to evaluate both central and distal airway mucosa.
Journal ArticleDOI

Thyroid cancer invading the airway: diagnosis and management.

TL;DR: Although some patients are currently referred with a severely advanced disease, the indication for tracheotomy, salvage procedures or supportive care has decreased over time and Resection is feasible for differentiated tumors with an overall good outcome.
Journal ArticleDOI

Enhanced recovery after thoracic surgery: patient information and care-plans.

TL;DR: Evaluating patient information and care-plans in thoracic surgery, reviewing the available evidence on ERAS pathways, and demonstrating the ideal program as discussed and shared among the Italian Thoracic Surgery Units accredited in the video-assisted thorACic surgery (VATS) group are aimed at.
Journal ArticleDOI

Identification of the intersegmental plane during thoracoscopic segmentectomy: state of the art.

TL;DR: In conclusion, ISP demarcation is mandatory to achieve a high rate of success of thoracoscopic segmentectomy, and it is very helpful in surgical planning, especially when preoperative multidetector computed tomography and 3-dimensional reconstructions are routinely performed.
Journal ArticleDOI

B-type natriuretic peptide following thoracic surgery: a predictor of postoperative cardiopulmonary complications

TL;DR: The results show that BNP elevation, measured in the first days after thoracic surgery, is independently associated with postoperative adverse events and in patients undergoing major pulmonary resections, a postoperative B NP elevation is the strongest independent predictor of cardiopulmonary complications.